학술논문

ASTRIS: a global real-world study of osimertinib in >3000 patients with T790M positive non-small-cell lung cancer.
Document Type
journal article
Source
Future Oncology; Sep2019, Vol. 15 Issue 25, p3003-3014, 12p
Subject
THERAPEUTIC use of antineoplastic agents
LUNG cancer diagnosis
ACRYLAMIDE
ALLELES
AMINES
AMINO acids
ANTINEOPLASTIC agents
CELL receptors
LUNG cancer
LUNG tumors
GENETIC mutation
PROGNOSIS
TUMOR classification
TREATMENT effectiveness
PROTEIN kinase inhibitors
KAPLAN-Meier estimator
Language
ISSN
14796694
Abstract
Copyright of Future Oncology is the property of Future Medicine Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)